FDA Drug Application (021711) for ABLAVAR by LANTHEUS MEDCL

Back to FDA Applications sponsored by LANTHEUS MEDCL

Application Number021711
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage2440MG/10ML (244MG/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABLAVAR
Active IngredientGADOFOSVESET TRISODIUM



Back to FDA Applications sponsored by LANTHEUS MEDCL